Fig. 5: DEPDC1A regulated bladder cancer development in vitro.
From: ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A
A, E Celigo cell counting assay was employed to show the effects of DEPDC1A on cell proliferation of EJ and T24 cells. B, F Flow cytometry was performed to detect cell apoptosis of EJ and T24 cells with or without DEPDC1A knockdown (B)/overexpression (F). C, D, G, H The effects of DEPDC1A on cell migration ability of EJ and T24 cells were evaluated by wound-healing assay (C, G) and Transwell assay (D, H). The representative images were selected from at least three independent experiments. Data were shown as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001.
